Get verified contacts for 2 Rare-X employees.
Search employees
The most common RARE-X email format is
[first][last_initial]
, which is being used by
100.0%
of RARE-X employees.
Other common email formats used by Rare-X's employees are
[first_initial][last]
,
[first]
,
[first]_[last]
,
[first].[last]
,
[first][last]
,
[first_initial][last_initial]
.
In total, Rare-X uses 7 work email formats.
Rare-X Email Format with Examples
Email format
Example
[first][last_initial]
johnd@rare-x.org
100%
Rare-X Questions
RARE-X's website is rare-x.org
RARE-X's LinkedIn profile is https://www.linkedin.com/company/rare-x
RARE-X has
2 employees.
View email and phone details for 2
employees at RARE-X.
RARE-X's industry is
Data Infrastructure and Analytics
RARE-X's top competitors are
National Organization For Rare Disorders,
Cure Rare Disease,
Rare Disease Foundation,
Rare Disease Day,
Rare Patient Voice,
Rare Diseases International,
Global Genes,
Everylife Foundation For Rare Diseases,
Rare Diseases Clinical Research Network (Rdcrn),
Rare Revolution Magazine.
RARE-X's categories are Data Infrastructure and Analytics
RARE-X's founding year is 2020
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.